Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial - Refardt, J; Imber, C; Nobbenhuis, R (J Am Soc Nephrol, 2023)
et al.